4.5 Review

Sarcolipin and phospholamban as regulators of cardiac sarcoplasmic reticulum Ca2+ ATPase

Journal

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
Volume 42, Issue 5, Pages 903-911

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.yjmcc.2007.03.738

Keywords

SERCA2a; sarcolipin; phospholamban; calcium; regulation

Funding

  1. NHLBI NIH HHS [R01 HL064140, R01 HL064140-09, R01-HL64140, R01 HL088555, R01 HL088555-01A1] Funding Source: Medline

Ask authors/readers for more resources

The cardiac sarcoplasmic reticulum calcium ATPase (SERCA2a) plays a critical role in maintaining the intracellular calcium homeostasis during cardiac contraction and relaxation. It has been well documented over the years that altered expression and activity of SERCA2a can lead to systolic and diastolic dysfunction. The activity of SERCA2a is regulated by two structurally similar proteins, phospholamban (PLB) and sarcolipin (SLN). Although, the relevance of PLB has been extensively studied over the years, the role SLN in cardiac physiology is an emerging field of study. This review focuses on the advances in the understanding of the regulation of SERCA2a by SLN and PLB. In particular, it highlights the similarities and differences between the two proteins and their roles in cardiac patho-physiology. (C) 2007 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available